Richards A L, Leonenko G, Walters J T, Kavanagh D H, Rees E G, Evans A, Chambert K D, Moran J L, Goldstein J, Neale B M, McCarroll S A, Pocklington A J, Holmans P A, Owen M J, O'Donovan M C
MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Cardiff CF24 4HQ, UK.
MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Hadyn Ellis Building, Cardiff CF24 4HQ, UK, Icahn School of Medicine at Mount Sinai, 1468 Madison Ave, New York, NY 10029, USA.
Hum Mol Genet. 2016 Mar 1;25(5):1001-7. doi: 10.1093/hmg/ddv620. Epub 2016 Jan 5.
Schizophrenia is a highly heritable disorder. Genome-wide association studies based largely on common alleles have identified over 100 schizophrenia risk loci, but it is also evident from studies of copy number variants (CNVs) and from exome-sequencing studies that rare alleles are also involved. Full characterization of the contribution of rare alleles to the disorder awaits the deployment of sequencing technology in very large sample sizes, meanwhile, as an interim measure, exome arrays allow rare non-synonymous variants to be sampled at a fraction of the cost. In an analysis of exome array data from 13 688 individuals (5585 cases and 8103 controls) from the UK, we found that rare (minor allele frequency < 0.1%) variant association signal was enriched among genes that map to autosomal loci that are genome-wide significant (GWS) in common variant studies of schizophrenia genome-wide association study (PGWAS = 0.01) as well as gene sets known to be enriched for rare variants in sequencing studies (PRARE = 0.026). We also identified the gene-wise equivalent of GWS support for WDR88 (WD repeat-containing protein 88), a gene of unknown function (P = 6.5 × 10(-7)). Rare alleles represented on exome chip arrays contribute to the genetic architecture of schizophrenia, but as is the case for GWAS, very large studies are required to reveal additional susceptibility alleles for the disorder.
精神分裂症是一种高度可遗传的疾病。全基因组关联研究主要基于常见等位基因,已确定了100多个精神分裂症风险位点,但从拷贝数变异(CNV)研究和外显子组测序研究中也可明显看出,罕见等位基因也参与其中。要全面了解罕见等位基因对该疾病的贡献,尚需在非常大的样本量中应用测序技术。同时,作为一项临时措施,外显子组芯片能够以较低成本对罕见的非同义变异进行采样。在对来自英国的13688名个体(5585例患者和8103名对照)的外显子组芯片数据进行分析时,我们发现,在精神分裂症全基因组关联研究(PGWAS = 0.01)中,在全基因组显著(GWS)的常染色体位点上定位的基因以及在测序研究中已知富含罕见变异的基因集中,罕见(次要等位基因频率<0.1%)变异关联信号更为丰富(PRARE = 0.026)。我们还确定了对WDR88(含WD重复蛋白88)基因的基因水平上相当于GWS的支持,该基因功能未知(P = 6.5×10⁻⁷)。外显子组芯片阵列上所代表的罕见等位基因对精神分裂症的遗传结构有贡献,但与全基因组关联研究的情况一样,需要开展非常大规模的研究才能揭示该疾病更多的易感等位基因。